ECRG4 and ECRG1 Interaction in Esophageal Cancer
Author Information
Author(s): Li Lin-wei, Li Yuan-yuan, Li Xiao-yan, Zhang Chun-peng, Zhou Yun, Lu Shih-Hsin
Primary Institution: Henan Provincial People's Hospital, Zhengzhou, P.R. China
Hypothesis
ECRG4 interacts with ECRG1 to inhibit cancer cell growth in esophageal carcinoma.
Conclusion
ECRG4 interacts directly with ECRG1 to upregulate p21 protein expression, induce cell cycle G1 phase block, and inhibit cancer cell proliferation in esophageal squamous cell carcinoma.
Supporting Evidence
- ECRG4 and ECRG1 co-expression significantly increased p21 protein levels.
- Co-transfection of ECRG4 and ECRG1 induced cell cycle G1 phase block.
- ECRG4 and ECRG1 co-expression inhibited cancer cell proliferation.
Takeaway
ECRG4 and ECRG1 work together to stop cancer cells from growing by blocking their cycle and increasing a protein called p21.
Methodology
Binding affinity assays, co-immunoprecipitation, Western blot analysis, and cell proliferation assays were used to study the interaction between ECRG4 and ECRG1.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website